Cystic Fibrosis Diagnosis and Evaluation

Cystic Fibrosis diagnosis relies on newborn screening, clinical assessment, and lab tests. Early evaluation allows proactive care and organ protection.

How Is Cystic Fibrosis Diagnosed Early?

Modern medicine allows most Cystic Fibrosis (CF) cases to be identified through newborn screening before the baby leaves the hospital. Early diagnosis is crucial to prevent permanent lung damage or severe malnutrition.

Diagnosis combines clinical symptoms, family history, and laboratory tests. Once confirmed, lifelong monitoring begins to track the health of affected organs.

Newborn Screening (Heel Prick Test)

In many countries, a blood sample is taken from the baby’s heel within the first few days of life.

• IRT (Immunoreactive Trypsinogen): High levels of this protein in the blood can be a marker for pancreatic stress associated with CF.
• Important Note: A high IRT level does not confirm CF; it simply indicates that further, more specific testing is required.

The Sweat Test

The sweat test is the most reliable tool for confirming a CF diagnosis.

• The Procedure: A medicine that triggers sweating is applied to a small patch of skin on the arm or leg.
• The Measurement: The chloride concentration in the sweat is measured. People with CF have much higher levels of chloride (typically 60 mmol/L or higher) because the defective CFTR protein cannot reabsorb salt properly.

Genetic Testing

• This involves analyzing DNA to look for mutations in the CFTR gene.

  • Scope: Since there are over 2,000 mutations, labs usually screen for the most common ones.
  • Clinical Value: Knowing the specific mutation is essential for determining which "CFTR Modulator" drugs (targeted therapies) will be effective for the patient.

Pulmonary Function Tests (PFTs)

• Once a child is old enough to follow instructions (usually age 5 or 6), PFTs are used to measure lung health.

  • Spirometry: Measures how much air the lungs can hold and how quickly the patient can exhale, indicating the degree of airway obstruction.

Sputum Culture

Regular samples of mucus from the throat or lungs are tested for bacteria.

• Goal: To catch dangerous bacteria like Pseudomonas or Staphylococcus early, allowing for targeted antibiotic treatment.

Imaging Studies

Doctors use imaging to monitor structural changes in the lungs and sinuses:

• Chest X-ray and CT Scan: To identify airway widening (bronchiectasis) or areas of inflammation and infection.
• Sinus CT: To evaluate chronic sinusitis and nasal polyps.

Pancreatic and Digestive Evaluation

Tests are conducted to see how well the body is absorbing nutrients:

• Fecal Elastase Test: Measures the amount of a specific enzyme in the stool to see if the pancreas is producing enough digestive enzymes.
• Blood Panels: Regular checks of fat-soluble vitamin levels (A, D, E, K).

Liver Function Tests (LFTs)

Because bile ducts can become blocked, annual blood tests and ultrasounds are performed to check for liver scarring (cirrhosis) or gallbladder issues.

Oral Glucose Tolerance Test (OGTT)

Starting at age 10, patients undergo annual screening for Cystic Fibrosis-Related Diabetes (CFRD). This is crucial because CFRD often has no symptoms in its early stages.

Bone Density Scan (DEXA)

Since malabsorption affects bone health, bone density is monitored starting in adolescence to prevent early-onset osteoporosis. 

How Does Liv Hospital Diagnose and Evaluate Cystic Fibrosis?

At Liv Hospital, we combine clinical expertise with advanced lab technology. Our Pediatric Pulmonology unit performs international-standard Sweat Tests and comprehensive Genetic Sequencing.
From diagnosis onward, a multidisciplinary team including gastroenterologists, endocrinologists, and nutritionists creates a baseline health map.
At Liv Hospital, diagnosis marks the start of a lifelong, holistic care journey to protect every breath.